A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 8,810 shares of ITCI stock, worth $752,990. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8,810
Previous 3,085 185.58%
Holding current value
$752,990
Previous $211,000 205.21%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

BUY
$67.99 - $80.84 $389,242 - $462,809
5,725 Added 185.58%
8,810 $644,000
Q2 2024

Jul 16, 2024

BUY
$64.76 - $79.84 $199,784 - $246,306
3,085 New
3,085 $211,000

Others Institutions Holding ITCI

About Intra-Cellular Therapies, Inc.


  • Ticker ITCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 94,401,696
  • Market Cap $8.07B
  • Description
  • Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...
More about ITCI
Track This Portfolio

Track Wealth Enhancement Advisory Services, LLC Portfolio

Follow Wealth Enhancement Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealth Enhancement Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealth Enhancement Advisory Services, LLC with notifications on news.